On September 9, 2014 (the “Closing Date”), Mindesta, Inc. entered into a Share Exchange Agreement with CTT Pharmaceuticals, Inc., f/k/a Fenwafe Inc., and the shareholders of CTT Pharma whereby Mindesta acquired all of the issued and outstanding shares of common stock of CTT Pharma in consideration for the issuance of 149,183,285 shares of Mindesta common stock of which CTT Pharma instructed Mindesta to issue 8,444,337 to Capital Financial. Pursuant to the Share Exchange Agreement at closing the following individuals were appointed as officers and directors of the Company: Dr. Pankaj Modi, Dr. Allen Greenspoon and Dean Hanisch. At the time of Closing, Gregory Bowes tendered his resignation as an officer and director of the Company.